Showing results (61-70 of 560) with videos related to

Sort By:
Pageof 56
Clinical Colorectal Cancer|November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control StudyHamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.
BMJ Open|February 6, 2025
Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UKManuel Rodriguez-Justo, Wasat Mansoor, Thomas Bird, et al.
Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.
Therapeutic Advances in Medical Oncology|January 25, 2021
Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence studyClare Shaw, Naureen Starling, Adam Reich, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Oncotargets and Therapy|June 19, 2024
Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor-Pretreated FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma: Case ReportPaolo D d'Arienzo, Alan R MacDonald, Virjen Patel, et al.
BJC Reports|November 8, 2024
Incidental finding of leukaemia in circulating tumour DNA- the importance of a molecular tumour boardJustin Mencel, Neha Rayarel, Paula Proszek, et al.
Frontiers in Oncology|December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patientsHazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Future Science OA|July 9, 2025
The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancerKaren Bartley, Jeremy Snider, Cheryl Cho-Phan, et al.
Pageof 56